{"disease":{"id":"seasonal-influenza","name":"seasonal influenza"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06602024","title":"A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":40817,"lead_sponsor_name":"ModernaTX, Inc.","has_results":false},{"nct_id":"NCT05566639","title":"A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults 50 Years Old and Older","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":22502,"lead_sponsor_name":"ModernaTX, Inc.","has_results":true},{"nct_id":"NCT05827978","title":"Study of mRNA-1010 Seasonal Influenza Vaccine in Adults","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":8411,"lead_sponsor_name":"ModernaTX, Inc.","has_results":true},{"nct_id":"NCT05415462","title":"A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":6102,"lead_sponsor_name":"ModernaTX, Inc.","has_results":true},{"nct_id":"NCT06049927","title":"A Phase III Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 Months","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":3300,"lead_sponsor_name":"Sinovac Biotech Co., Ltd","has_results":false},{"nct_id":"NCT03853993","title":"Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (15µg/0.5ml)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2380,"lead_sponsor_name":"Sinovac Biotech Co., Ltd","has_results":false},{"nct_id":"NCT03859141","title":"Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (7.5μg/0.25ml)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2340,"lead_sponsor_name":"Sinovac Biotech Co., Ltd","has_results":false},{"nct_id":"NCT05431725","title":"Immunogenicity and Safety Study of Influenza Vaccine (Split Virion), Inactivated, Quadrivalent","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2202,"lead_sponsor_name":"Sinovac Biotech Co., Ltd","has_results":false},{"nct_id":"NCT05512494","title":"Lot-to-lot Consistency of Quadrivalent Influenza Vaccine (Split Virion), Inactivated","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":1260,"lead_sponsor_name":"Sinovac Biotech Co., Ltd","has_results":false},{"nct_id":"NCT04133584","title":"The Immunogenicity and Safety of the Vaccination of Inactivated Enterovirus 71 Vaccine and Seasonal Influenza Vaccine","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":1134,"lead_sponsor_name":"Zhejiang Provincial Center for Disease Control and Prevention","has_results":false},{"nct_id":"NCT04956575","title":"A Study of mRNA-1010 Seasonal Influenza Vaccine in Healthy Adults","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":885,"lead_sponsor_name":"ModernaTX, Inc.","has_results":true},{"nct_id":"NCT05827068","title":"A Study of mRNA-1011.1, mRNA-1011.2, and mRNA-1012.1 Candidate Seasonal Influenza Vaccines in Healthy Adults","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":698,"lead_sponsor_name":"ModernaTX, Inc.","has_results":true},{"nct_id":"NCT04997239","title":"A Clinical Trial of Quadrivalent Influenza Vaccine in Children Aged 3-8 Years Old","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":600,"lead_sponsor_name":"Sinovac Biotech Co., Ltd","has_results":false},{"nct_id":"NCT05333289","title":"A Study of mRNA-1020 and mRNA-1030 Seasonal Influenza Vaccines in Healthy Adults","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":572,"lead_sponsor_name":"ModernaTX, Inc.","has_results":true},{"nct_id":"NCT05397223","title":"A Study of Modified mRNA Vaccines in Healthy Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":308,"lead_sponsor_name":"ModernaTX, Inc.","has_results":false},{"nct_id":"NCT05245552","title":"A Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 Months","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":217,"lead_sponsor_name":"Sinovac Biotech Co., Ltd","has_results":false},{"nct_id":"NCT04896086","title":"First-in-Human Clinical Trial of a Mosaic Quadrivalent Influenza Vaccine Compared With a Licensed Inactivated Seasonal QIV in Healthy Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":63,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT02547792","title":"Assessment of an Oral Influenza B Vaccine Tablet (VXA-BYW.10) Following Single Dose Administration in Healthy Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":54,"lead_sponsor_name":"Vaxart","has_results":false},{"nct_id":"NCT06863142","title":"Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":45,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT05129436","title":"Adaptive Immune Response to Seasonal Influenza Vaccination (AIGI)","phase":"","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"University Medicine Greifswald","has_results":false},{"nct_id":"NCT03121339","title":"Pharmacodynamic Open-Label Trial With VXA-A1.1 Oral H1 Vaccine in Healthy Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"Vaxart","has_results":false}],"total":21},"guidelines":[],"source":"Drug Landscape verified database"}